Review



massarray detection platform  (agena bioscience)


Bioz Verified Symbol agena bioscience is a verified supplier
Bioz Manufacturer Symbol agena bioscience manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    agena bioscience massarray detection platform
    Massarray Detection Platform, supplied by agena bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/massarray+detection+system/massarray+platform/pmc09910734-173-0-3
    Average 90 stars, based on 1 article reviews
    massarray detection platform - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Declining Outcrossing Rates Inside Orchard Blocks of ‘Maluma’ and ‘Shepard’ Avocado ( Persea americana Mill.) Trees: Effects on Fruit Yield and Quality
    Article Snippet: We genotyped each embryo using the Agena MassARRAY platform (Agena Bioscience, San Diego, CA, USA) to assign paternity to each fruit.

    Article Title: Association of VEGFA Gene Polymorphisms with the Susceptibility of Coronary Heart Disease in the Chinese Han Population.
    Article Snippet: Coronary heart disease (CHD) is a prevalent cardiovascular' condition characterized by high morbidity and mortality rates, with a significant genetic component.. The VEGFA gene plays a crucial role in the development of CHD.. This study aims to evaluate the influence of VEGFA gene polymorphisms on CHD susceptibility.

    Article Title: Genetic and epigenetic variations of the glucocorticoid receptor gene (NR3C1) and cognition in major depressive disorder.
    Article Snippet: Introduction: Many studies have found that hypothalamic‒pituitary‒adrenal (HPA) axis abnormalities are related to the pathophysiology of major depressive disorder (MDD) and cognitive functioning.. Our aim was to assess the influence of genetic polymorphisms and methylation levels in three different promoter regions throughout the glucocorticoid receptor (GR) gene NR3C1 on cognitive performance in MDD.. Plausible interactions with childhood adversity and mediation relationships between genetic and epigenetic variables were explored.

    Article Title: Seven loci associated with schizophrenia and bipolar I disorder in selected southern African population groups.
    Article Snippet: All 150 samples were analysed with the Agena Bioscience MassARRAY® platform (Agena® Bioscience, San Diego, CA, United States) for the 20 selected variants (Table 1).

    Article Title: Seven loci associated with schizophrenia and bipolar I disorder in selected southern African population groups.
    Article Snippet: Genotyping of the selected loci was performed with the Agena Bioscience MassARRAY® platform on 96 cases (58 schizophrenia and 38 bipolar I disorder patients) and 44 controls of Afrikaner, Sotho, and Tswana descent.

    Article Title: Investigating the role of eight SNPs in CHRNA3 for COPD susceptibility in the Chinese elderly population.
    Article Snippet: Bioengineering (shanghai co., ltd, china) was entrusted with the synthesis of these primers. to ensure precise genotyping of the eight snPs in CHRNA3, the agena MassaRRaY platform from agena Bioscience (san diego, ca, Usa) was employed.

    Article Title: CYP2D6 polymorphism rs1065852 significantly increases the risk of type 2 diabetes
    Article Snippet: We used the Agena MassARRAY platform (Agena Bioscience, San Diego, CA) to genotype five SNPs in CYP2C8 and CYP2D6 following the manufacturer’s instructions [ ].

    Article Title: Multiomics Analysis of a Micronutrient-Rich Dietary Pattern and the Aging Genotype 9p21 on the Plasma Proteome of Young Adults
    Article Snippet: Genotyping was completed using the iPLEX Gold assay with mass-spectrometry-based detection (Sequenom MassARRAY platform; Agena Bioscience, San Diego, CA, USA) at the Clinical Genome Centre at Princess Margaret Hospital, University Health Network in Toronto, Canada, as described previously [ ].



    Similar Products

    kit for the qualitative detection of sars-cov-2 using rt-pcr reaction together with the massarray system  (agena bioscience)
    90
    agena bioscience kit for the qualitative detection of sars-cov-2 using rt-pcr reaction together with the massarray system
    Kit For The Qualitative Detection Of Sars Cov 2 Using Rt Pcr Reaction Together With The Massarray System, supplied by agena bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/massarray+detection+system/massarray+sars+cov+2+panel/pm36747014-37-9-18
    Average 90 stars, based on 1 article reviews
    kit for the qualitative detection of sars-cov-2 using rt-pcr reaction together with the massarray system - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    massarray detection platform  (agena bioscience)
    90
    agena bioscience massarray detection platform
    Massarray Detection Platform, supplied by agena bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/massarray+detection+system/massarray+platform/pmc09910734-173-0-3
    Average 90 stars, based on 1 article reviews
    massarray detection platform - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    commercial kit for the qualitative detection of sars-cov-2 using rt-pcr reaction together with the massarray system  (agena bioscience)
    90
    agena bioscience commercial kit for the qualitative detection of sars-cov-2 using rt-pcr reaction together with the massarray system
    Comparison of SARS-CoV-2 variant identification using Next Generation Sequencing (NGS) and MassARRY PMA-ABDO and PMA-Omicron (n = 358).
    Commercial Kit For The Qualitative Detection Of Sars Cov 2 Using Rt Pcr Reaction Together With The Massarray System, supplied by agena bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/massarray+detection+system/massarray+sars+cov+2+panel/pmc09900542-103-9-18
    Average 90 stars, based on 1 article reviews
    commercial kit for the qualitative detection of sars-cov-2 using rt-pcr reaction together with the massarray system - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    iplex® gold massarray maldi-tof ms detection  (Sequenom)
    90
    Sequenom iplex® gold massarray maldi-tof ms detection
    Comparison of SARS-CoV-2 variant identification using Next Generation Sequencing (NGS) and MassARRY PMA-ABDO and PMA-Omicron (n = 358).
    Iplex® Gold Massarray Maldi Tof Ms Detection, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/massarray+detection+system/maldi+tof+mass+spectrometry+iplex+platform/pmc04299921-50-6-5
    Average 90 stars, based on 1 article reviews
    iplex® gold massarray maldi-tof ms detection - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    agena massarray methylation detection  (agena bioscience)
    96
    agena bioscience agena massarray methylation detection
    Comparison of SARS-CoV-2 variant identification using Next Generation Sequencing (NGS) and MassARRY PMA-ABDO and PMA-Omicron (n = 358).
    Agena Massarray Methylation Detection, supplied by agena bioscience, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/massarray+detection+system/Methylation/ppr0552502-125-0-0
    Average 96 stars, based on 1 article reviews
    agena massarray methylation detection - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier
    massarray methylation detection  (Sequenom)
    90
    Sequenom massarray methylation detection
    A A negative correlation between ZNF334 <t>methylation</t> level and its mRNA expression (Pearson r = −0.53, R 2 = 0.28) B mRNA expression of ZNF334 in cancer and adjacent tissues of 213 liver cancer patients. C Western-blot diagram of ZNF334 expression in cancer and adjacent tissues of 12 liver cancer patients. D Methylation mass spectrum primers of ZNF334 promoter region and mass spectrometry detection product sequence (green indicates the EPIC chip probe cg07139762 site, which is in the ZNF334 promoter region; yellow indicates the <t>MassARRAY</t> methylation mass spectrometry detection sites, a total of 29). E Heat map of methylation level of ZNF334 promoter region in cancer and adjacent tissues of 25 patients with liver cancer. F The ratio of methylation degree of ZNF334 promoter in cancer and adjacent tissues (T/P) of 25 patients with liver cancer. G The average methylation degree of ZNF334 promoter in cancer and adjacent tissues of 25 patients with liver cancer. **** p < 0.0001.
    Massarray Methylation Detection, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/massarray+detection+system/massarray+quantitative+methylation+analysis/pmc09085879-231-0-4
    Average 90 stars, based on 1 article reviews
    massarray methylation detection - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    massarray sequenom detection  (Sequenom)
    90
    Sequenom massarray sequenom detection
    A A negative correlation between ZNF334 methylation level and its mRNA expression (Pearson r = −0.53, R 2 = 0.28) B mRNA expression of ZNF334 in cancer and adjacent tissues of 213 liver cancer patients. C Western-blot diagram of ZNF334 expression in cancer and adjacent tissues of 12 liver cancer patients. D Methylation mass spectrum primers of ZNF334 promoter region and mass spectrometry detection product sequence (green indicates the EPIC chip probe cg07139762 site, which is in the ZNF334 promoter region; yellow indicates the <t>MassARRAY</t> methylation mass spectrometry detection sites, a total of 29). E Heat map of methylation level of ZNF334 promoter region in cancer and adjacent tissues of 25 patients with liver cancer. F The ratio of methylation degree of ZNF334 promoter in cancer and adjacent tissues (T/P) of 25 patients with liver cancer. G The average methylation degree of ZNF334 promoter in cancer and adjacent tissues of 25 patients with liver cancer. **** p < 0.0001.
    Massarray Sequenom Detection, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/massarray+detection+system/sequenom+massarray/pmc09085879-184-7-8
    Average 90 stars, based on 1 article reviews
    massarray sequenom detection - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    massarray dna mass spectrometry detection  (agena bioscience)
    90
    agena bioscience massarray dna mass spectrometry detection
    A A negative correlation between ZNF334 methylation level and its mRNA expression (Pearson r = −0.53, R 2 = 0.28) B mRNA expression of ZNF334 in cancer and adjacent tissues of 213 liver cancer patients. C Western-blot diagram of ZNF334 expression in cancer and adjacent tissues of 12 liver cancer patients. D Methylation mass spectrum primers of ZNF334 promoter region and mass spectrometry detection product sequence (green indicates the EPIC chip probe cg07139762 site, which is in the ZNF334 promoter region; yellow indicates the <t>MassARRAY</t> methylation mass spectrometry detection sites, a total of 29). E Heat map of methylation level of ZNF334 promoter region in cancer and adjacent tissues of 25 patients with liver cancer. F The ratio of methylation degree of ZNF334 promoter in cancer and adjacent tissues (T/P) of 25 patients with liver cancer. G The average methylation degree of ZNF334 promoter in cancer and adjacent tissues of 25 patients with liver cancer. **** p < 0.0001.
    Massarray Dna Mass Spectrometry Detection, supplied by agena bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/massarray+detection+system/massarray+mass+spectrometer/pm34260825-63-8-13
    Average 90 stars, based on 1 article reviews
    massarray dna mass spectrometry detection - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    massarray snp detection  (Sequenom)
    90
    Sequenom massarray snp detection
    A A negative correlation between ZNF334 methylation level and its mRNA expression (Pearson r = −0.53, R 2 = 0.28) B mRNA expression of ZNF334 in cancer and adjacent tissues of 213 liver cancer patients. C Western-blot diagram of ZNF334 expression in cancer and adjacent tissues of 12 liver cancer patients. D Methylation mass spectrum primers of ZNF334 promoter region and mass spectrometry detection product sequence (green indicates the EPIC chip probe cg07139762 site, which is in the ZNF334 promoter region; yellow indicates the <t>MassARRAY</t> methylation mass spectrometry detection sites, a total of 29). E Heat map of methylation level of ZNF334 promoter region in cancer and adjacent tissues of 25 patients with liver cancer. F The ratio of methylation degree of ZNF334 promoter in cancer and adjacent tissues (T/P) of 25 patients with liver cancer. G The average methylation degree of ZNF334 promoter in cancer and adjacent tissues of 25 patients with liver cancer. **** p < 0.0001.
    Massarray Snp Detection, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/massarray+detection+system/sequenom+massarray/pmc08787141-153-1-0
    Average 90 stars, based on 1 article reviews
    massarray snp detection - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Comparison of SARS-CoV-2 variant identification using Next Generation Sequencing (NGS) and MassARRY PMA-ABDO and PMA-Omicron (n = 358).

    Journal: Scientific Reports

    Article Title: Simultaneous detection of omicron and other SARS-CoV-2 variants by multiplex PCR MassARRAY technology

    doi: 10.1038/s41598-023-28715-9

    Figure Lengend Snippet: Comparison of SARS-CoV-2 variant identification using Next Generation Sequencing (NGS) and MassARRY PMA-ABDO and PMA-Omicron (n = 358).

    Article Snippet: Recently, the commercial kit for the qualitative detection of SARS-CoV-2 using RT-PCR reaction together with the MassARRAY system (Agena Bioscience ® , San Diego, CA, USA) has been developed, and it showed superiority over Real-time PCR assay .

    Techniques: Comparison, Variant Assay, Next-Generation Sequencing

    A A negative correlation between ZNF334 methylation level and its mRNA expression (Pearson r = −0.53, R 2 = 0.28) B mRNA expression of ZNF334 in cancer and adjacent tissues of 213 liver cancer patients. C Western-blot diagram of ZNF334 expression in cancer and adjacent tissues of 12 liver cancer patients. D Methylation mass spectrum primers of ZNF334 promoter region and mass spectrometry detection product sequence (green indicates the EPIC chip probe cg07139762 site, which is in the ZNF334 promoter region; yellow indicates the MassARRAY methylation mass spectrometry detection sites, a total of 29). E Heat map of methylation level of ZNF334 promoter region in cancer and adjacent tissues of 25 patients with liver cancer. F The ratio of methylation degree of ZNF334 promoter in cancer and adjacent tissues (T/P) of 25 patients with liver cancer. G The average methylation degree of ZNF334 promoter in cancer and adjacent tissues of 25 patients with liver cancer. **** p < 0.0001.

    Journal: Cell Death & Disease

    Article Title: DNA hypermethylation modification promotes the development of hepatocellular carcinoma by depressing the tumor suppressor gene ZNF334

    doi: 10.1038/s41419-022-04895-6

    Figure Lengend Snippet: A A negative correlation between ZNF334 methylation level and its mRNA expression (Pearson r = −0.53, R 2 = 0.28) B mRNA expression of ZNF334 in cancer and adjacent tissues of 213 liver cancer patients. C Western-blot diagram of ZNF334 expression in cancer and adjacent tissues of 12 liver cancer patients. D Methylation mass spectrum primers of ZNF334 promoter region and mass spectrometry detection product sequence (green indicates the EPIC chip probe cg07139762 site, which is in the ZNF334 promoter region; yellow indicates the MassARRAY methylation mass spectrometry detection sites, a total of 29). E Heat map of methylation level of ZNF334 promoter region in cancer and adjacent tissues of 25 patients with liver cancer. F The ratio of methylation degree of ZNF334 promoter in cancer and adjacent tissues (T/P) of 25 patients with liver cancer. G The average methylation degree of ZNF334 promoter in cancer and adjacent tissues of 25 patients with liver cancer. **** p < 0.0001.

    Article Snippet: MassARRAY methylation detection technology (Sequenom, USA) performed by CapitalBio Technology (Shanghai, China) was used to detect the methylation level of ZNF334 promoter (human) in carcinoma and paracancerous tissues of 25 HCC patients and Zfp334 promoter (mice) in treatment and control group.

    Techniques: Methylation, Expressing, Western Blot, Mass Spectrometry, Sequencing

    A A negative correlation between ZNF334 methylation level and its mRNA expression (Pearson r = −0.53, R 2 = 0.28) B mRNA expression of ZNF334 in cancer and adjacent tissues of 213 liver cancer patients. C Western-blot diagram of ZNF334 expression in cancer and adjacent tissues of 12 liver cancer patients. D Methylation mass spectrum primers of ZNF334 promoter region and mass spectrometry detection product sequence (green indicates the EPIC chip probe cg07139762 site, which is in the ZNF334 promoter region; yellow indicates the MassARRAY methylation mass spectrometry detection sites, a total of 29). E Heat map of methylation level of ZNF334 promoter region in cancer and adjacent tissues of 25 patients with liver cancer. F The ratio of methylation degree of ZNF334 promoter in cancer and adjacent tissues (T/P) of 25 patients with liver cancer. G The average methylation degree of ZNF334 promoter in cancer and adjacent tissues of 25 patients with liver cancer. **** p < 0.0001.

    Journal: Cell Death & Disease

    Article Title: DNA hypermethylation modification promotes the development of hepatocellular carcinoma by depressing the tumor suppressor gene ZNF334

    doi: 10.1038/s41419-022-04895-6

    Figure Lengend Snippet: A A negative correlation between ZNF334 methylation level and its mRNA expression (Pearson r = −0.53, R 2 = 0.28) B mRNA expression of ZNF334 in cancer and adjacent tissues of 213 liver cancer patients. C Western-blot diagram of ZNF334 expression in cancer and adjacent tissues of 12 liver cancer patients. D Methylation mass spectrum primers of ZNF334 promoter region and mass spectrometry detection product sequence (green indicates the EPIC chip probe cg07139762 site, which is in the ZNF334 promoter region; yellow indicates the MassARRAY methylation mass spectrometry detection sites, a total of 29). E Heat map of methylation level of ZNF334 promoter region in cancer and adjacent tissues of 25 patients with liver cancer. F The ratio of methylation degree of ZNF334 promoter in cancer and adjacent tissues (T/P) of 25 patients with liver cancer. G The average methylation degree of ZNF334 promoter in cancer and adjacent tissues of 25 patients with liver cancer. **** p < 0.0001.

    Article Snippet: And meanwhile, in clinical samples, we used MassArray Sequenom detection to further verify the DNA methylation changes of ZNF334 promoter in cancerous tissues and adjacent tissues.

    Techniques: Methylation, Expressing, Western Blot, Mass Spectrometry, Sequencing